Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-03-03 @ 12:02 AM
Study NCT ID:
NCT02732327
Status:
TERMINATED
Last Update Posted:
2017-07-21
First Post:
2016-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Sponsor:
Forest Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CAZ-MD-13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None